Celsion Corporation (NASDAQ:CLSN)

CAPS Rating: 1 out of 5

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.


Player Avatar mdriver78 (62.24) Submitted: 12/17/2012 11:19:04 AM : Underperform Start Price: $40.10 CLSN Score: +85.03

Run on early stage trials is usually short lived and price tends to return to the base trading line.

Member Avatar YARDBIRD6 (42.90) Submitted: 12/18/2012 12:15:43 AM
Recs: 0

i will wait until January, don't like the cancer word, took mom, and i couldn't do a thing

Featured Broker Partners